Cargando…
Identification of Prognostic and Metastatic Alternative Splicing Signatures in Kidney Renal Clear Cell Carcinoma
Background: Kidney renal clear cell carcinoma (KIRC) is the malignancy originated from the renal epithelium, with a high rate of distant metastasis. Aberrant alternative splicing (AS) of pre-mRNA are widely reported to be involved in the tumorigenesis and metastasis of multiple cancers. The aim of t...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6803439/ https://www.ncbi.nlm.nih.gov/pubmed/31681747 http://dx.doi.org/10.3389/fbioe.2019.00270 |
_version_ | 1783460932397039616 |
---|---|
author | Meng, Tong Huang, Runzhi Zeng, Zhiwei Huang, Zongqiang Yin, Huabin Jiao, ChenChen Yan, Penghui Hu, Peng Zhu, Xiaolong Li, Zhenyu Song, Dianwen Zhang, Jie Cheng, Liming |
author_facet | Meng, Tong Huang, Runzhi Zeng, Zhiwei Huang, Zongqiang Yin, Huabin Jiao, ChenChen Yan, Penghui Hu, Peng Zhu, Xiaolong Li, Zhenyu Song, Dianwen Zhang, Jie Cheng, Liming |
author_sort | Meng, Tong |
collection | PubMed |
description | Background: Kidney renal clear cell carcinoma (KIRC) is the malignancy originated from the renal epithelium, with a high rate of distant metastasis. Aberrant alternative splicing (AS) of pre-mRNA are widely reported to be involved in the tumorigenesis and metastasis of multiple cancers. The aim of this study is to explore the mechanism of alternative splicing events (ASEs) underlying tumorigenesis and metastasis of KIRC. Methods: RNA-seq of 537 KIRC samples downloaded from the TCGA database and ASEs data from the TCGASpliceSeq database were used to identify ASEs in patients with KIRC. The univariate and Lasso regression analysis were used to screen the most significant overall survival-related ASEs (OS-SEs). Based on those, the OS-SEs model was proposed. The interaction network of OS-SEs and splicing factors (SFs) with absolute value of correlation coefficient value >0.750 was constructed by Pearson correlation analysis. The OS-SEs significantly related to distant metastasis and clinical stage were identified by non-parametric test, and those were also integrated into co-expression analysis with prognosis-related Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways identified by Gene Set Variation Analysis (GSVA). ASEs with significance were selected for multiple online database validation. Results: A total of prognostic 6,081 overall survival-related ASEs (OS-SEs) were identified by univariate Cox regression analysis and a prediction model was constructed based on 5 OS-SEs screened by Lasso regression with the Area Under Curve of 0.788. Its risk score was also illustrated to be an independent predictor, which the good reliability of the model. Among 390 identified candidate SFs, DExD-Box Helicase 39B (DDX39B) was significantly correlated with OS and metastasis. After external database validation, Retained Intron of Ras Homolog Family Member T2 (RHOT2) and T-Cell Immune Regulator 1 (TCIRG1) were identified. In the co-expression analysis, overlapped co-expression signal pathways for RHOT2 and TCIRG1 were sphingolipid metabolism and N-glycan biosynthesis. Conclusions: Based on the results of comprehensive bioinformatic analysis, we proposed that aberrant DDX39B regulated RHOT2-32938-RI and TCIRG1-17288-RI might be associated with the tumorigenesis, metastasis, and poor prognosis of KIRC via sphingolipid metabolism or N-glycan biosynthesis pathway. |
format | Online Article Text |
id | pubmed-6803439 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-68034392019-11-03 Identification of Prognostic and Metastatic Alternative Splicing Signatures in Kidney Renal Clear Cell Carcinoma Meng, Tong Huang, Runzhi Zeng, Zhiwei Huang, Zongqiang Yin, Huabin Jiao, ChenChen Yan, Penghui Hu, Peng Zhu, Xiaolong Li, Zhenyu Song, Dianwen Zhang, Jie Cheng, Liming Front Bioeng Biotechnol Bioengineering and Biotechnology Background: Kidney renal clear cell carcinoma (KIRC) is the malignancy originated from the renal epithelium, with a high rate of distant metastasis. Aberrant alternative splicing (AS) of pre-mRNA are widely reported to be involved in the tumorigenesis and metastasis of multiple cancers. The aim of this study is to explore the mechanism of alternative splicing events (ASEs) underlying tumorigenesis and metastasis of KIRC. Methods: RNA-seq of 537 KIRC samples downloaded from the TCGA database and ASEs data from the TCGASpliceSeq database were used to identify ASEs in patients with KIRC. The univariate and Lasso regression analysis were used to screen the most significant overall survival-related ASEs (OS-SEs). Based on those, the OS-SEs model was proposed. The interaction network of OS-SEs and splicing factors (SFs) with absolute value of correlation coefficient value >0.750 was constructed by Pearson correlation analysis. The OS-SEs significantly related to distant metastasis and clinical stage were identified by non-parametric test, and those were also integrated into co-expression analysis with prognosis-related Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways identified by Gene Set Variation Analysis (GSVA). ASEs with significance were selected for multiple online database validation. Results: A total of prognostic 6,081 overall survival-related ASEs (OS-SEs) were identified by univariate Cox regression analysis and a prediction model was constructed based on 5 OS-SEs screened by Lasso regression with the Area Under Curve of 0.788. Its risk score was also illustrated to be an independent predictor, which the good reliability of the model. Among 390 identified candidate SFs, DExD-Box Helicase 39B (DDX39B) was significantly correlated with OS and metastasis. After external database validation, Retained Intron of Ras Homolog Family Member T2 (RHOT2) and T-Cell Immune Regulator 1 (TCIRG1) were identified. In the co-expression analysis, overlapped co-expression signal pathways for RHOT2 and TCIRG1 were sphingolipid metabolism and N-glycan biosynthesis. Conclusions: Based on the results of comprehensive bioinformatic analysis, we proposed that aberrant DDX39B regulated RHOT2-32938-RI and TCIRG1-17288-RI might be associated with the tumorigenesis, metastasis, and poor prognosis of KIRC via sphingolipid metabolism or N-glycan biosynthesis pathway. Frontiers Media S.A. 2019-10-15 /pmc/articles/PMC6803439/ /pubmed/31681747 http://dx.doi.org/10.3389/fbioe.2019.00270 Text en Copyright © 2019 Meng, Huang, Zeng, Huang, Yin, Jiao, Yan, Hu, Zhu, Li, Song, Zhang and Cheng. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Bioengineering and Biotechnology Meng, Tong Huang, Runzhi Zeng, Zhiwei Huang, Zongqiang Yin, Huabin Jiao, ChenChen Yan, Penghui Hu, Peng Zhu, Xiaolong Li, Zhenyu Song, Dianwen Zhang, Jie Cheng, Liming Identification of Prognostic and Metastatic Alternative Splicing Signatures in Kidney Renal Clear Cell Carcinoma |
title | Identification of Prognostic and Metastatic Alternative Splicing Signatures in Kidney Renal Clear Cell Carcinoma |
title_full | Identification of Prognostic and Metastatic Alternative Splicing Signatures in Kidney Renal Clear Cell Carcinoma |
title_fullStr | Identification of Prognostic and Metastatic Alternative Splicing Signatures in Kidney Renal Clear Cell Carcinoma |
title_full_unstemmed | Identification of Prognostic and Metastatic Alternative Splicing Signatures in Kidney Renal Clear Cell Carcinoma |
title_short | Identification of Prognostic and Metastatic Alternative Splicing Signatures in Kidney Renal Clear Cell Carcinoma |
title_sort | identification of prognostic and metastatic alternative splicing signatures in kidney renal clear cell carcinoma |
topic | Bioengineering and Biotechnology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6803439/ https://www.ncbi.nlm.nih.gov/pubmed/31681747 http://dx.doi.org/10.3389/fbioe.2019.00270 |
work_keys_str_mv | AT mengtong identificationofprognosticandmetastaticalternativesplicingsignaturesinkidneyrenalclearcellcarcinoma AT huangrunzhi identificationofprognosticandmetastaticalternativesplicingsignaturesinkidneyrenalclearcellcarcinoma AT zengzhiwei identificationofprognosticandmetastaticalternativesplicingsignaturesinkidneyrenalclearcellcarcinoma AT huangzongqiang identificationofprognosticandmetastaticalternativesplicingsignaturesinkidneyrenalclearcellcarcinoma AT yinhuabin identificationofprognosticandmetastaticalternativesplicingsignaturesinkidneyrenalclearcellcarcinoma AT jiaochenchen identificationofprognosticandmetastaticalternativesplicingsignaturesinkidneyrenalclearcellcarcinoma AT yanpenghui identificationofprognosticandmetastaticalternativesplicingsignaturesinkidneyrenalclearcellcarcinoma AT hupeng identificationofprognosticandmetastaticalternativesplicingsignaturesinkidneyrenalclearcellcarcinoma AT zhuxiaolong identificationofprognosticandmetastaticalternativesplicingsignaturesinkidneyrenalclearcellcarcinoma AT lizhenyu identificationofprognosticandmetastaticalternativesplicingsignaturesinkidneyrenalclearcellcarcinoma AT songdianwen identificationofprognosticandmetastaticalternativesplicingsignaturesinkidneyrenalclearcellcarcinoma AT zhangjie identificationofprognosticandmetastaticalternativesplicingsignaturesinkidneyrenalclearcellcarcinoma AT chengliming identificationofprognosticandmetastaticalternativesplicingsignaturesinkidneyrenalclearcellcarcinoma |